相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The β-Arrestin Pathway-selective Type 1A Angiotensin Receptor (AT1A) Agonist [Sar1, Ile4, Ile8] Angiotensin II Regulates a Robust G Protein-independent Signaling Network
Ryan T. Kendall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Intracellular Cannabinoid Type 1 (CB1) Receptors Are Activated by Anandamide
G. Cristina Brailoiu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Histidine 6.55 Is a Major Determinant of Ligand-Biased Signaling in Dopamine D2L Receptor
Nuska Tschammer et al.
MOLECULAR PHARMACOLOGY (2011)
Crystal structure of metarhodopsin II
Hui-Woog Choe et al.
NATURE (2011)
The structural basis of agonist-induced activation in constitutively active rhodopsin
Jorg Standfuss et al.
NATURE (2011)
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Soren G. F. Rasmussen et al.
NATURE (2011)
Identification of an antithrombotic allosteric modulator that acts through helix 8 of PAR1
Louisa Dowal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
Arun K. Shukla et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
β-arrestin-mediated receptor trafficking and signal transduction
Sudha K. Shenoy et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Differential Effects of Allosteric M1 Muscarinic Acetylcholine Receptor Agonists on Receptor Activation, Arrestin 3 Recruitment, and Receptor Downregulation
Albert A. Davis et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Cannabinoid Receptor 1 trafficking and the role of the intracellular pool: Implications for therapeutics
Natasha L. Grimsey et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Hydrophobic Residues in Helix 8 of Cannabinoid Receptor 1 Are Critical for Structural and Functional Properties
Kwang H. Ahn et al.
BIOCHEMISTRY (2010)
Identification of Orthosteric and Allosteric Site Mutations in M2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias
Karen J. Gregory et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Signal transduction of the CB1 cannabinoid receptor
Gabor Turu et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2010)
Ligand-Induced Regulation and Localization of Cannabinoid CB1 and Dopamine D2L Receptor Heterodimers
Julie A. Przybyla et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
How Does Arrestin Assemble MAPKs into a Signaling Complex?
Xiufeng Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Contrasting Effects of Allosteric and Orthosteric Agonists on M-1 Muscarinic Acetylcholine Receptor Internalization and Down-regulation
Rachel L. Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Dual Role of the Second Extracellular Loop of the Cannabinoid Receptor 1: Ligand Binding and Receptor Localization
Kwang H. Ahn et al.
MOLECULAR PHARMACOLOGY (2009)
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
P. Jeffrey Conn et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Multiple Switches in G Protein-Coupled Receptor Activation
Shivani Ahuja et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway
Chol Seung Lim et al.
CELLULAR SIGNALLING (2008)
Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3
Raphael Rozenfeld et al.
FASEB JOURNAL (2008)
Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells
Barbara Bosier et al.
FEBS LETTERS (2008)
Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism
Tanya L. Daigle et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors
Arun K. Shukla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
beta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERKs) translocate to nucleus in contrast to G protein-dependent ERK activation
Hui Zheng et al.
MOLECULAR PHARMACOLOGY (2008)
PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats
J. G. Horswill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
β-arrestin-biased ligands at seven-transmembrane receptors
Jonathan D. Violin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Conformational complexity of G-protein-coupled receptors
Brian K. Kobilka et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor
Neil A. McDonald et al.
MOLECULAR PHARMACOLOGY (2007)
Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1
Lene Martini et al.
FASEB JOURNAL (2007)
The emerging functions of endocannabinoid signaling during CNS development
Tibor Harkany et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082
Kenneth A. Pelkey et al.
NEUROPHARMACOLOGY (2007)
Allosteric modulation of muscarinic acetylcholine receptors
Karen J. Gregory et al.
CURRENT NEUROPHARMACOLOGY (2007)
A guided tour into subcellular colocalization analysis in light microscopy
S. Bolte et al.
JOURNAL OF MICROSCOPY (2006)
A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation
Aaron M. D'Antona et al.
BRAIN RESEARCH (2006)
Mutations of CB1 T210 produce active and inactive receptor forms:: Correlations with ligand affinity, receptor stability, and cellular localization
AM D'Antona et al.
BIOCHEMISTRY (2006)
Distinct β-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation
D Gesty-Palmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors
C Leterrier et al.
JOURNAL OF NEUROSCIENCE (2006)
β-arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor
SK Shenoy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox
Christopher J. Langmead et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Allosteric modulation of the cannabinoid CB1 receptor
MR Price et al.
MOLECULAR PHARMACOLOGY (2005)
Allosteric modulators affect the internalization of human adenosine A1 receptors
EC Klaasse et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Constitutive endocytic cycle of the CB1 cannabinoid receptor
C Leterrier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Involvement of the Carboxyl Terminus of the Third Intracellular Loop of the Cannabinoid CB1 Receptor in Constitutive Activation of Gs
Vasiliki Abadji et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
HJ Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A
JW Murphy et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
GL Johnson et al.
SCIENCE (2002)
Retrograde signaling by endocannabinoids
AC Kreitzer et al.
CURRENT OPINION IN NEUROBIOLOGY (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
G protein-coupled receptor allosterism and complexing
A Christopoulos et al.
PHARMACOLOGICAL REVIEWS (2002)
Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus
P Derkinderen et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The endocannabinoid nervous system: unique opportunities for therapeutic intervention
AC Porter et al.
PHARMACOLOGY & THERAPEUTICS (2001)
Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
LM Luttrell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cellular signal transduction by anandamide and 2-arachidonoylglycerol
AC Howlett et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2000)
β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2
KA DeFea et al.
JOURNAL OF CELL BIOLOGY (2000)